Exporter

You can select particular sections to be included in the output file.
EN
FR

Liste modèle des médicaments essentiels

effacer Trouvé 75 recommandations pour 17 médicaments et 2 équivalents thérapeutiques
Les médicaments retirés et les demandes rejetées ne sont pas indiqués. Les afficher.
6.2.2. Watch group antibiotics
  1. Azithromycin Informations générales
    Section
    Watch group antibiotics
    • Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
    • Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)
    Indications
    Premier choix
    Trachoma Cholera Cholera [children] Paratyphoid fever Chlamydia trachomatis Typhoid fever Yaws co-prescrite avec ceftriaxone Gonococcal infection
    Second choix
    Infectious gastroenteritis or colitis without specification of infectious agent co-prescrite avec cefixime Gonococcal infection
  2. Cefixime Informations générales
    Section
    Watch group antibiotics
    • Oral > Liquid: 100 mg per 5 mL powder for oral liquid
    • Oral > Solid: 200 mg (as trihydrate); 400 mg (as trihydrate)
    Indications
    Second choix
    Infectious gastroenteritis or colitis without specification of infectious agent Gonococcal infection
  3. Cefotaxime Informations générales
    Section
    Watch group antibiotics
    • Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
    Indications
    Premier choix
    Bacterial meningitis Inflammatory and other diseases of prostate (severe) Acute pyelonephritis (severe) Bacterial pneumonia (Community-acquired pneumonia - severe) [children] Bacterial pneumonia (Community-acquired pneumonia - severe) Peritoneal abscess (mild-moderate) Peritoneal abscess (severe) Other specified pneumonia (Hospital-acquired pneumonia) Peritonitis (mild-moderate) Peritonitis (severe)
    Second choix
    Inflammatory and other diseases of prostate (mild to moderate) Acute pyelonephritis (mild to moderate) Sepsis without septic shock Bacterial infection of joint Osteomyelitis or osteitis
  4. Ceftazidime Informations générales
    Section
    Watch group antibiotics
    • Parenteral > General injections > unspecified: 250 mg in vial (as pentahydrate) powder for injection; 1 g in vial (as pentahydrate) powder for injection
    Indications
    Premier choix
    Endophthalmitis
    Autres indications
    Pseudomonas aeruginosa resistant to other antibiotic
  5. Ceftriaxone Informations générales
    Section
    Watch group antibiotics
    • Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
    • Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
    • Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
    • Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial
    Indications
    Premier choix
    Inflammatory and other diseases of prostate (severe) Bacterial meningitis Acute pyelonephritis (severe) Other specified pneumonia (Hospital-acquired pneumonia) Paratyphoid fever Typhoid fever Peritonitis (mild-moderate) Peritonitis (severe) Peritoneal abscess (mild-moderate) Peritoneal abscess (severe) Gonococcal infection Endophthalmitis Bacterial pneumonia (Community-acquired pneumonia - severe) Bacterial pneumonia (Community-acquired pneumonia - severe) [children] co-prescrite avec metronidazole Necrotising fasciitis
    Second choix
    Inflammatory and other diseases of prostate (mild to moderate) Acute pyelonephritis (mild to moderate) Infectious gastroenteritis or colitis without specification of infectious agent Bacterial infection of joint Sepsis without septic shock Osteomyelitis or osteitis
  6. Cefuroxime Informations générales
    Section
    Watch group antibiotics
    • Parenteral > General injections > IV: 250 mg in vial (as sodium salt) powder for injection; 750 mg in vial (as sodium salt) powder for injection; 1.5 g in vial (as sodium salt) powder for injection
    Indications
    Second choix
    Other specified prophylactic measures
  7. Ciprofloxacin Informations générales
    Section
    Watch group antibiotics
    • Parenteral > General injections > IV: 2 mg per mL (as hyclate)
    • Oral > Liquid: 250 mg per 5 mL (anhydrous)
    • Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
    • Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)
    Indications
    Premier choix
    Acute pyelonephritis (mild to moderate) Infectious gastroenteritis or colitis without specification of infectious agent Paratyphoid fever Typhoid fever Neutropenia (low-risk) Inflammatory and other diseases of prostate (mild to moderate)
    Second choix
    Cholera Cholera [children] Peritonitis (mild-moderate) Peritoneal abscess (mild-moderate)
  8. Clarithromycin Informations générales
    Section
    Watch group antibiotics
    • Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid
    • Parenteral > General injections > unspecified: 500 mg in vial powder for injection
    • Oral > Solid > dosage form: 500 mg; 250 mg
    • Oral > Solid > dosage form: 500 mg
    Indications
    Premier choix
    co-prescrite avec cefotaxime Bacterial pneumonia (Community-acquired pneumonia - severe) co-prescrite avec ceftriaxone Bacterial pneumonia (Community-acquired pneumonia - severe)
    Second choix
    Acute pharyngitis co-prescrite avec amoxicillin + clavulanic acid Bacterial pneumonia (Community-acquired pneumonia - severe)
    Autres indications
    Helicobacter pylori associated gastric ulcer
  9. Erythromycin Informations générales
    Section
    Watch group antibiotics
    Indications
    Second choix
    Therapeutic equivalent to clarithromycin pour Acute pharyngitis
  10. Imipenem + cilastatin Informations générales
    Section
    Watch group antibiotics
    Indications
    Second choix
    Therapeutic equivalent to meropenem pour Peritonitis (severe) Therapeutic equivalent to meropenem pour Peritoneal abscess (severe) Therapeutic equivalent to meropenem pour Neutropenia (high-risk)
  11. Meropenem Informations générales
    Section
    Watch group antibiotics
    • Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection
    Indications
    Second choix
    Neonatal meningitis Peritonitis (severe) Peritoneal abscess (severe) Neutropenia (high-risk)
  12. Piperacillin + tazobactam Informations générales
    Section
    Watch group antibiotics
    • Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection
    Indications
    Premier choix
    Neutropenia (high-risk) Other specified pneumonia (Hospital-acquired pneumonia) Peritonitis (severe) Peritoneal abscess (severe) co-prescrite avec clindamycin Necrotising fasciitis
  13. Vancomycin Informations générales
    Section
    Watch group antibiotics
    • Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride)
    • Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection
    • Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection
    Indications
    Premier choix
    Necrotising fasciitis co-prescrite avec ceftazidime Endophthalmitis co-prescrite avec ceftriaxone Endophthalmitis
    Second choix
    Intestinal infections due to Clostridioides difficile Neutropenia (high-risk)